Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Jan 23:20:97-100.
doi: 10.12659/AJCR.912875.

Acute Unilateral Vision Loss Due to Optic Neuropathy in a Patient with Systemic Lupus Erythematosus

Affiliations
Case Reports

Acute Unilateral Vision Loss Due to Optic Neuropathy in a Patient with Systemic Lupus Erythematosus

Alexander J Heckman et al. Am J Case Rep. .

Abstract

BACKGROUND Systemic lupus erythematosus (SLE) causes sight-threatening, ophthalmologic problems that are frequently challenging to manage. Optic neuropathy is a rare ophthalmological complication of SLE that can progress to total bilateral vision loss if not identified and treated rapidly. We describe a patient with SLE who presented with an acute, painless unilateral optic neuropathy who subsequently experienced partial recovery of vision when treated with high-dose intravenous corticosteroids. CASE REPORT A 44-year-old female with known SLE presented with 4 days of painless, complete, and gradual vision loss in the right eye. Initial ophthalmologic examination revealed no light perception, afferent pupil defect, 4+ optic disc swelling, and 1+ venous tortuosity of the right eye. No hemorrhage or exudates were noted. Diagnostic workup revealed a lupus flare with elevated inflammatory markers including elevated anti-nuclear antibody, anti-ds-DNA antibody, anti-Sm antibody, and anti-phospholipid IgG antibody. The diagnosis of optic neuropathy was clinically established, and the patient was treated with high-dose intravenous corticosteroids. Her vision improved, and she was transitioned to oral corticosteroids with eventual significant improvement in her vision. CONCLUSIONS Optic neuropathy is a rare and devastating ophthalmologic complication of SLE. The diagnosis can be made by linking key clinical findings on ophthalmologic examination with positive serological studies. If treated rapidly with immunosuppressive therapy, the vision loss can be reversed, and permanent blindness avoided. Although this rare complication is generally bilateral in nature, clinician must also be aware of unilateral disease and treat patients accordingly.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared

Conflicts of interest

None.

Figures

Figure 1.
Figure 1.
Funduscopic examination of a patient with optic neuropathy demonstrating an edematous, pale optic disc.
Figure 2.
Figure 2.
A fluorescein angiogram of lupus retinal vasculitis. Prominent features include scattered intraretinal hemorrhages, fluorescein leakage from the optic disc, vascular leakage from the large veins, and peripheral capillary non-perfusion

References

    1. Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheum. 2002;16(5):847–58. - PubMed
    1. Semon HC, Wolff E. Acute lupus erythematosus, with fundus lesions. Proc R Soc Med. 1933;27:153–57. - PMC - PubMed
    1. Palejwala NV, Walia HS, Yeh S. Ocular manifestations of systemic lupus erythematosus: A review of the literature. Autoimmune Dis. 2012;2012:290898. - PMC - PubMed
    1. de Andrade FA, Guimaraes Moreira Balbi G, Bortoloti de Azevedo LG, et al. Neuro-ophthalmologic manifestations in systemic lupus erythematosus. Lupus. 2017;26(5):522–28. - PubMed
    1. Silpa-archa S, Lee JJ, Foster CS. Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol. 2016;100(1):135–41. - PubMed

Publication types

Substances